ASCO GU represents one of the yearly highlights in the field of genitourinary cancer. During BMUC 2018 the key data presented at this meeting were summarized.
By: Dr. D. De Maeseneer , Dr. F-X. Otte and Dr. S. Albisinni
ASCO GU represents one of the yearly highlights in the field of genitourinary cancer. During BMUC 2018 the key data presented at this meeting were summarized.
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
